Scarlet Therapeutics
Bristol · Founded 2022
About Scarlet Therapeutics
Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
Company Facts
- Founded: 2022
- Legal name: Scarlet Therapeutics Limited
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.4M
- Funding stage: Seed
- Last round: Seed (May 2023)
- Website: scarlet-tx.com
Social Profiles
Canonical: https://fsome.com/organization/scarlet-therapeutics-8370747 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.